NUTX
HealthcareNutex Health, Inc. · Medical - Healthcare Information Services · $710M
What is Nutex Health, Inc.?
Nutex Health is a technology-enabled healthcare services company headquartered in Houston, Texas. It combines physical care facilities with a proprietary data platform to serve patients and physician networks across the United States.
Nutex Health operates through two divisions. The Hospital division owns and runs micro-hospitals, specialty hospitals, and hospital outpatient departments across eight states. The Population Health Management division operates independent physician associations and management services organizations. A cloud-based proprietary technology platform ties both divisions together, aggregating patient and provider data from multiple sources to support coordinated care delivery and administrative efficiency.
Nutex Health was incorporated in 2022 and is headquartered in Houston, Texas.
- Micro-hospitals and specialty hospital facilities
- Hospital outpatient department operations
- Independent physician association networks
- Cloud-based population health management platform
- Management and administrative services for affiliated providers
Is NUTX a Good Stock to Buy?
UQS Score rates NUTX as Good overall, reflecting a mixed but constructive profile across its five pillars.
The Quality pillar stands out as the clearest strength, suggesting the business generates returns that compare favorably relative to its size and stage. Growth and Risk both register as Good, indicating the company is expanding while keeping its risk profile at a manageable level for a small-cap healthcare operator.
The Moat pillar is rated Weak, meaning Nutex has not yet established the durable competitive advantages that would protect its market position over the long term.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does NUTX pay dividends?
No — Nutex Health, Inc. does not currently pay a dividend.
Nutex Health does not currently pay a dividend. As a growth-oriented small-cap company still expanding its facility footprint and technology platform, capital is directed toward building out operations rather than returning cash to shareholders. Investors seeking income may want to look elsewhere, while those focused on growth may view reinvestment as appropriate at this stage.
When does NUTX report earnings?
Nutex Health reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
The company's Good Growth and Quality pillar ratings suggest its financial results have been trending in a constructive direction relative to its peer group. Revenue generation across both the Hospital and Population Health Management divisions contributes to the overall picture.
For the most recent quarter's results and guidance, visit Nutex Health's investor relations page directly.
NUTX Price History
-92.5% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Nutex Health, Inc.?
Based on Nutex Health, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
NUTX Long-term Outlook
Nutex Health's Good Growth pillar points to a business that is expanding its operational base, supported by a growing network of facilities and an evolving technology platform. The Good Risk rating suggests the company is navigating execution challenges without excessive financial strain. However, the Weak Moat rating is a meaningful caveat — sustained growth may face pressure if competitors replicate the micro-hospital or population health model without significant differentiation barriers in place.
Growth drivers
- Expansion of micro-hospital and specialty facility footprint across new states
- Scaling the cloud-based population health platform to serve more physician networks
- Growing demand for outpatient and community-based care models
Key risks
- Limited competitive moat leaves the model vulnerable to replication by larger healthcare systems
- Small-cap scale means operational missteps can have outsized financial impact
- Regulatory and reimbursement changes in the healthcare sector could affect facility economics
NUTX vs Peers
Nutex Health operates in a fragmented healthcare technology and services landscape alongside several companies that address overlapping aspects of care delivery and data management.
HealthStream focuses on workforce development and learning management for healthcare organizations, rather than operating physical care facilities.
Phreesia specializes in patient intake and engagement software, targeting the administrative front end of care rather than facility operations or physician network management.
GoodRx operates a consumer-facing prescription pricing and telehealth platform, addressing medication affordability rather than hospital or population health infrastructure.
Frequently Asked Questions
What does Nutex Health do?
Nutex Health operates micro-hospitals, specialty hospitals, and hospital outpatient departments across eight states through its Hospital division. Its Population Health Management division runs independent physician associations and uses a cloud-based platform to aggregate patient and provider data, supporting coordinated care and administrative services for affiliated groups.
Does NUTX pay dividends?
Nutex Health does not currently pay a dividend. The company is in a growth phase, directing capital toward expanding its facility network and technology platform rather than distributing cash to shareholders.
When does NUTX report earnings?
Nutex Health follows a standard quarterly earnings cadence for US-listed companies. For the exact timing of upcoming reports, check the investor relations section of the Nutex Health website or a financial calendar service.
Is NUTX a good stock to buy?
UQS Score rates NUTX as Good overall. The Quality and Growth pillars are constructive, while the Weak Moat rating signals limited competitive insulation at this stage. Whether it fits your portfolio depends on your risk tolerance and investment goals. The full pillar breakdown is available to UQS Pro members.
Is NUTX overvalued?
The UQS Valuation pillar for NUTX is rated Attractive, suggesting the stock is not trading at a stretched premium relative to its fundamentals. Valuation is one of five pillars in the UQS composite — view the complete analysis on the full score page.
How does NUTX compare to its competitors?
Nutex Health occupies a distinct niche by combining physical healthcare facilities with a population health technology platform. Peers like HealthStream, Phreesia, and GoodRx focus on narrower software or consumer-facing segments without operating hospital infrastructure. This makes direct comparisons nuanced across the group.
What is NUTX's market cap bracket?
Nutex Health is classified as a small-cap company. This means it carries higher volatility and liquidity risk than large- or mega-cap peers, but may also offer greater growth potential if its facility and technology expansion strategy executes successfully.
Who founded Nutex Health?
Nutex Health's founding and leadership background is publicly available through the company's official filings and investor relations materials. The company was incorporated in 2022 and is headquartered in Houston, Texas.
Is NUTX a long-term quality investment?
As a long-term quality indicator, the UQS Score rates NUTX as Good. The Quality pillar is Strong, which is a positive signal for durability. However, the Weak Moat rating means the company has not yet demonstrated the entrenched competitive advantages typically associated with high-conviction long-term holdings. Pro members can view the full pillar detail.
What is the main competitive advantage of Nutex Health?
Nutex Health's differentiation lies in combining physical care facilities with a proprietary cloud-based population health platform. This integrated model — spanning micro-hospitals, physician networks, and data aggregation — is relatively uncommon among small-cap healthcare operators, though the UQS Moat pillar currently rates this advantage as Weak.
What sector does NUTX belong to?
Nutex Health operates in the Healthcare sector, specifically at the intersection of healthcare services and health technology. Its dual-division model spans facility-based care delivery and technology-driven population health management, giving it exposure to both segments of the broader healthcare market.
Unlock Full NUTX Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar ratings
- ✓Access detailed financial metrics and trend data
- ✓Compare NUTX against sector peers side by side
- ✓See the complete Quality and Moat breakdown
- ✓Track score changes with portfolio watchlist alerts
- ✓Get the full analyst-style view in one place
Pro Analysis
NUTX — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | 70.0 | 92.5 | 32.0 | 69.1 | 76.3 | 100.0 | +0.5 |
| May 4, 2026 | 69.5 | 88.6 | 32.0 | 67.0 | 73.0 | 100.0 | +0.1 |
| Apr 2, 2026 | 69.4 | 88.6 | 32.0 | 66.4 | 73.0 | 100.0 | — |
NUTX — Pillar Breakdown
Quality
— 92.5/100 (25%)Nutex Health, Inc. demonstrates outstanding capital efficiency and profitability, placing it among the highest-quality businesses in the market.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 69.1/100 (20%)Nutex Health, Inc. demonstrates healthy growth trends across revenue and earnings.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 76.3/100 (15%)Nutex Health, Inc. carries minimal financial risk with conservative leverage and strong solvency.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 100.0/100 (15%)Nutex Health, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 32/100 (25%)Nutex Health, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for NUTX.
Score Composition
Financial Data
More Stock Analysis
How is the NUTX UQS Score Calculated?
The UQS (Unified Quality Score) for Nutex Health, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Nutex Health, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Nutex Health, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.